Reuters logo
5 months ago
BRIEF-Kadmon presents preclinical data supporting therapeutic potential of rock inhibition in pulmonary fibrosis
March 28, 2017 / 2:12 PM / 5 months ago

BRIEF-Kadmon presents preclinical data supporting therapeutic potential of rock inhibition in pulmonary fibrosis

March 28 (Reuters) - Kadmon Holdings Inc

* Kadmon presents preclinical data supporting the therapeutic potential of rock inhibition in pulmonary fibrosis

* Kadmon Holdings Inc - data validate role of rock signaling in fibrotic disease

* Kadmon Holdings Inc - data demonstrate that rock inhibition blocks multiple cell signaling mechanisms that drive pulmonary fibrosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below